AzTrials
AzTrials

KneePhase 1NCT07685561

Restoration of Knee Extension After ACL Reconstruction

A Phase 1 study testing Standard Physical Therapy and Ermi Knee Extensionater in people with Knee and ACL, run by University of Alabama at Birmingham at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to determine whether the addition of a home-based high-intensity knee extension stretching device (Ermi Knee Extensionater) to standard postoperative physical therapy improves recovery of full knee extension following ACL reconstruction compared with standard physical therapy alone. Read more about this study

Who is it for?
Ages 14 to 65 years
Conditions the study is for
Knee, ACL
What is being tested?
Standard Physical Therapy and Ermi Knee Extensionater
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteUnited States
Study dates
Dec 2026to Mar 2032
Phase
Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Age 14-65 yo
  • Primary ACLR (BTB auto ONLY)
  • Prior ACL tear treated non-op

Who cannot join

  • Revision ACL surgery
  • Major concomitant ligament reconstruction
  • Neurologic lower-extremity disorder
  • Inability to complete rehab
  • Cognitive impairment preventing consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Amit Momaya, MD contact

(205) 930-8494

amomaya@uabmc.edu

United States1 site
  • University of Alabama at Birmingham

    Birmingham, Alabama, 35243

    Amit Momaya, MD, (205) 930-8494, amomaya@uabmc.edu

    Camille Crane, (303) 652 - 7821,, camillecrane@uabmc.edu

Other trials in United States

About this study

Official title: Restoration of Knee Extension After ACL Reconstruction: A Comparison of Standard Physical Therapy With and Without Adjunct Mechanical Stretching

The purpose of this study is to determine whether the addition of a home-based high-intensity knee extension stretching device (Ermi Knee Extensionater) to standard postoperative physical therapy improves recovery of full knee extension following ACL reconstruction compared with standard physical therapy alone.

Conditions
Knee, ACL
Being tested
Standard Physical Therapy, Ermi Knee Extensionater
Keywords
ACL, Knee, knee reconstruction, Ermi Knee Extensionator

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard Physical TherapyBehavioural

    Routine standard physical therapy for post op knee reconstructive surgery. May include use of knee Extensionator in a clinic setting.

  • Ermi Knee ExtensionaterDevice

    Standard rehabilitation protocol plus daily home use of the Knee Extensionater for terminal extension stretching.

    The Ermi device will be distributed to all participants in Arm 2 preoperatively. Stretching protocols will be provided at this time. Following surgery, participants must complete daily home stretching sessions (60 total minutes of end-range stretching per day) starting at postoperative day one. Each stretching session is broken down into 10 minutes of stretching, followed by 10 minutes of rest. This is repeated throughout the day until a total of 60 minutes of stretching is completed. There should be at least one hour between sessions. Stretching sessions will continue until 3 months postop.

Study groups in NCT07685561
Study groupRoleWhat they receive
Participants Receiving Standard of CareActive comparatorPatients will receive standard physical therapy alone: postoperative rehabilitation as per the treating clinician's standard ACL protocol (this may include use of the Knee Extensionater in a clinical setting).
Receives: Behavioral: Standard Physical Therapy
Patient Receiving Ermi Knee Extensionator + Standard of CareExperimentalPatients will receive the Ermi Knee Extensionater plus standard physical therapy: Standard rehabilitation protocol plus daily home use of the Knee Extensionater for terminal extension stretching.
Receives: Behavioral: Standard Physical Therapy; Device: Ermi Knee Extensionater

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Knee Range of Motion

    A goniometer will be used to measure the post operative knee's range of motion an angle or to rotate an object to a precise angular position.

    Measured: Baseline, 2 weeks, 6 weeks, and 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2026
  2. Study startDec 2026 (estimated)
  3. Primary completionMar 2032 (estimated)
  4. Study completionMar 2032 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
58 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07685561
Sponsor's protocol ID
IRB-300016352
Other IDs
ERMI LLC Device
Status last verified
Oct 2026
First submitted
30 Jun 2026
Last updated
15 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Standard Physical Therapy and Ermi Knee Extensionater in people with Knee and ACL, run by University of Alabama at Birmingham at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Amit Momaya, MD ((205) 930-8494, amomaya@uabmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Knee Range of Motion (time frame: Baseline, 2 weeks, 6 weeks, and 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in